These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 27485003)
41. [CRISPR-Cas system as molecular scissors for gene therapy]. Heinz GA; Mashreghi MF Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743 [TBL] [Abstract][Full Text] [Related]
42. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future. Luo J Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053 [No Abstract] [Full Text] [Related]
43. Cancer Screens: Better Together. Pruett-Miller SM CRISPR J; 2020 Feb; 3(1):12-14. PubMed ID: 32091251 [No Abstract] [Full Text] [Related]
44. The Anti-CRISPR Story: A Battle for Survival. Maxwell KL Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512 [TBL] [Abstract][Full Text] [Related]
48. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation. Wang H; Sun W Cancer Lett; 2017 Jan; 385():137-143. PubMed ID: 27815036 [TBL] [Abstract][Full Text] [Related]
49. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy. Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008 [TBL] [Abstract][Full Text] [Related]